tirzepatide uk nhs Mounjaro weight loss jabs now available at GPs as begins mass rollout – are you eligible? New NHS Weight Management Medication

9.2% were severely obese

Regular monitoring ensures safe and balanced outcomes

The information provided in this section is intended solely for the use of registered medical practitioner

The FDA has recently announced a significant change in the availability of compounded tirzepatide, a medication known for its benefits in treating type 2 diabetes and supporting weight loss efforts

The staff is very friendly, super knowledgeable, and always available to answer any questions or help with any concerns

While both populations are primarily white and female, those taking tirzepatide are more likely to be younger, have at least some college education, have fewer co-morbidities, and not have type 2 diabetes